What is the recommended dose and direction for Robitussin (Guaifenesin) in adults?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Robitussin (Guaifenesin) Dosing for Adults

For adults, the recommended dose of guaifenesin (Robitussin) is 10 to 20 mL (200-400 mg) every 4 hours, not exceeding 6 doses in 24 hours. 1

Standard Dosing Regimen

Immediate-Release Formulation:

  • Dose: 10 to 20 mL (2 to 4 teaspoonfuls) every 4 hours 1
  • Maximum frequency: Do not exceed 6 doses in any 24-hour period 1
  • Timing: Multiple daily doses are needed to maintain therapeutic effect throughout the day due to guaifenesin's short half-life 2

Extended-Release Formulation Alternative

Extended-Release Tablets (if available):

  • Dose: 600-1200 mg every 12 hours 3
  • Advantage: Provides convenience with twice-daily dosing instead of every 4 hours 3
  • Bioequivalence: Extended-release formulations at 1200 mg every 12 hours are bioequivalent to 400 mg immediate-release every 4 hours 3

Administration Instructions

Key directions for optimal use:

  • Take with a full glass of water to enhance the expectorant effect 2
  • Can be taken with or without food, though food may delay time to peak concentration with extended-release formulations 3
  • The flexible dosing range (200-400 mg per dose) allows titration based on symptom severity 2

Mechanism and Clinical Use

How guaifenesin works:

  • Acts as an expectorant by loosening mucus in the airways and making coughs more productive 2
  • The expectorant action is mediated through stimulation of the gastrointestinal tract, not systemic absorption 4
  • Helps relieve wet cough and chest congestion associated with upper respiratory tract infections 2

Important Caveats

Limitations to be aware of:

  • Guaifenesin is the only legally marketed expectorant in the US per OTC Monograph 2
  • While it has FDA approval for helping loosen phlegm, objective evidence of antitussive (cough-suppressing) effect is limited 5
  • Patients reported subjective improvement in sputum thickness (96% vs 54% placebo) and quantity (88% vs 62% placebo) in clinical studies 5
  • The immediate-release liquid formulation requires frequent dosing every 4 hours to maintain 24-hour therapeutic effect 2

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.